Yong Chu

458 total citations
30 papers, 360 citations indexed

About

Yong Chu is a scholar working on Molecular Biology, Organic Chemistry and Cell Biology. According to data from OpenAlex, Yong Chu has authored 30 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 11 papers in Organic Chemistry and 5 papers in Cell Biology. Recurrent topics in Yong Chu's work include Wnt/β-catenin signaling in development and cancer (5 papers), PI3K/AKT/mTOR signaling in cancer (4 papers) and Sphingolipid Metabolism and Signaling (4 papers). Yong Chu is often cited by papers focused on Wnt/β-catenin signaling in development and cancer (5 papers), PI3K/AKT/mTOR signaling in cancer (4 papers) and Sphingolipid Metabolism and Signaling (4 papers). Yong Chu collaborates with scholars based in China, United States and South Korea. Yong Chu's co-authors include Deyong Ye, Binghe Wang, Lu Zhou, Hairong Hu, Peng Zhang, Zhi‐Ren Liu, Peng Zhang, Danzhu Wang, Peng Zhang and Brent W. Weston and has published in prestigious journals such as Chemical Communications, Journal of Medicinal Chemistry and Advanced Science.

In The Last Decade

Yong Chu

25 papers receiving 352 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yong Chu China 13 221 132 39 35 30 30 360
Yuli Xie United States 14 241 1.1× 150 1.1× 47 1.2× 18 0.5× 49 1.6× 26 486
D.M. Smith United States 8 200 0.9× 97 0.7× 41 1.1× 37 1.1× 49 1.6× 10 381
Antonio Limatola Italy 12 249 1.1× 92 0.7× 34 0.9× 25 0.7× 26 0.9× 16 475
Timothy B. Ware United States 7 187 0.8× 120 0.9× 13 0.3× 25 0.7× 15 0.5× 13 284
Frederick A. Brookfield United Kingdom 10 187 0.8× 80 0.6× 30 0.8× 17 0.5× 24 0.8× 10 336
Patrick Berna France 12 313 1.4× 88 0.7× 55 1.4× 19 0.5× 27 0.9× 18 505
Shuichi Mori Japan 14 240 1.1× 111 0.8× 14 0.4× 31 0.9× 11 0.4× 33 442
Chongwu Zhang United States 8 310 1.4× 205 1.6× 37 0.9× 26 0.7× 10 0.3× 9 424
Rhushikesh A. Kulkarni United States 11 287 1.3× 113 0.9× 18 0.5× 30 0.9× 62 2.1× 16 442
Laura Caboni Ireland 9 289 1.3× 76 0.6× 17 0.4× 17 0.5× 18 0.6× 11 441

Countries citing papers authored by Yong Chu

Since Specialization
Citations

This map shows the geographic impact of Yong Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yong Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yong Chu more than expected).

Fields of papers citing papers by Yong Chu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yong Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yong Chu. The network helps show where Yong Chu may publish in the future.

Co-authorship network of co-authors of Yong Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Yong Chu. A scholar is included among the top collaborators of Yong Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yong Chu. Yong Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Xu, Pengcheng, Lili Ji, Yanxia Zhan, et al.. (2025). YC‐4‐3, a Novel Glycogen Synthase Kinase 3β Inhibitor, Alleviates the Endoplasmic Reticulum Stress of Macrophages in Primary Immune Thrombocytopenia. Advanced Science. 12(17). e2412515–e2412515.
3.
Li, Chunpu, Haojie Wang, Mi Zhou, et al.. (2024). Discovery of Phenylpyrazole Derivatives as a New Class of Selective Inhibitors of MCL-1 with Antitumor Activity. ACS Omega. 9(25). 27369–27396. 4 indexed citations
4.
Chen, Miao, Song Zhang, Zhibing Luo, et al.. (2024). UK5099 Inhibits the NLRP3 Inflammasome Independently of its Long‐Established Target Mitochondrial Pyruvate Carrier. Advanced Science. 11(33). e2307224–e2307224. 8 indexed citations
5.
Qiu, Chenyang, et al.. (2024). Novel 4-triazole phenyl amide (4-TPA) molecules: Potent promoters of α-synuclein fibril disassembly. European Journal of Medicinal Chemistry. 273. 116490–116490. 2 indexed citations
6.
Xu, Yunsheng, et al.. (2024). Design, synthesis and evaluate of indazolylaminoquinazoline derivatives as potent Tropomyosin receptor kinase (TRK) inhibitors. Bioorganic & Medicinal Chemistry. 99. 117608–117608. 3 indexed citations
7.
Bian, Jiang, Xin Lin, Chenyang Qiu, et al.. (2021). Discovery of styrylaniline derivatives as novel alpha-synuclein aggregates ligands. European Journal of Medicinal Chemistry. 226. 113887–113887. 10 indexed citations
8.
Chen, Yanfei, Jiang Bian, Lu-Lu Bu, et al.. (2020). Design, synthesis and identification of N, N-dibenzylcinnamamide (DBC) derivatives as novel ligands for α-synuclein fibrils by SPR evaluation system. Bioorganic & Medicinal Chemistry. 28(7). 115358–115358. 12 indexed citations
9.
Chu, Yong, et al.. (2020). Small-molecule GLP-1 secretagogs: challenges and recent advances. Drug Discovery Today. 25(11). 2023–2029. 11 indexed citations
10.
Li, Yali, Bin Lou, Deyong Ye, et al.. (2018). Discovery, synthesis and anti-atherosclerotic activities of a novel selective sphingomyelin synthase 2 inhibitor. European Journal of Medicinal Chemistry. 163. 864–882. 23 indexed citations
11.
Ye, Deyong, et al.. (2017). The discovery of novel benzothiazinones as highly selective non-ATP competitive glycogen synthase kinase 3β inhibitors for the treatment of ovarian cancer. European Journal of Medicinal Chemistry. 135. 370–381. 10 indexed citations
12.
Li, Yali, Hui Jiang, Yanping Dong, et al.. (2015). Discovery, synthesis and biological evaluation of 2-(4-(N-phenethylsulfamoyl)phenoxy)acetamides (SAPAs) as novel sphingomyelin synthase 1 inhibitors. Bioorganic & Medicinal Chemistry. 23(18). 6173–6184. 15 indexed citations
13.
Zhang, Peng, Shufen Li, Wenbo Lu, et al.. (2014). Novel benzothiazinones (BTOs) as allosteric modulator or substrate competitive inhibitor of glycogen synthase kinase 3β (GSK-3β) with cellular activity of promoting glucose uptake. Bioorganic & Medicinal Chemistry Letters. 24(24). 5639–5643. 26 indexed citations
14.
Chu, Yong, Danzhu Wang, Ke Wang, et al.. (2013). Fluorescent conjugate of sLex-selective bisboronic acid for imaging application. Bioorganic & Medicinal Chemistry Letters. 23(23). 6307–6309. 29 indexed citations
15.
Zhang, Peng, et al.. (2012). Design, synthesis and biological evaluation of benzothiazepinones (BTZs) as novel non-ATP competitive inhibitors of glycogen synthase kinase-3β (GSK-3β). European Journal of Medicinal Chemistry. 61. 95–103. 32 indexed citations
16.
Zhang, Peng, et al.. (2012). Identification of novel scaffold of benzothiazepinones as non-ATP competitive glycogen synthase kinase-3β inhibitors through virtual screening. Bioorganic & Medicinal Chemistry Letters. 22(23). 7232–7236. 16 indexed citations
17.
Dai, Chaofeng, Lisa H. Cazares, Lifang Wang, et al.. (2011). Using boronolectin in MALDI-MS imaging for the histological analysis of cancer tissue expressing the sialyl Lewis X antigen. Chemical Communications. 47(37). 10338–10338. 39 indexed citations
18.
Chu, Yong, et al.. (2010). 2-(Furan-2-yl)-5-(2-nitrobenzyl)-2,3-dihydro-1,5-benzothiazepin-4(5H)-one. Acta Crystallographica Section E Structure Reports Online. 67(1). o168–o168.
19.
Chu, Yong, et al.. (2004). A PRACTICAL PROCEDURE FOR THE SYNTHESIS OF 3-((E)-5-(2,3,4,5-TETRAMETHOXY-6-METHYLPHENYL)-3METHYLPENT-3-ENYL)-2,2-DIMETHYLOXIRANE. Organic Preparations and Procedures International. 36(5). 476–479.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuli Xie Breakdown of academic impact, for papers by D.M. Smith Breakdown of academic impact, for papers by Antonio Limatola Breakdown of academic impact, for papers by Timothy B. Ware Breakdown of academic impact, for papers by Frederick A. Brookfield Breakdown of academic impact, for papers by Patrick Berna Breakdown of academic impact, for papers by Shuichi Mori Breakdown of academic impact, for papers by Chongwu Zhang Breakdown of academic impact, for papers by Rhushikesh A. Kulkarni Breakdown of academic impact, for papers by Laura Caboni
Rankless by CCL
2026